News
National Regulator Approves "Conditional Market Authorization" of Two ... - Latest Tweet by PIB India
The latest Tweet by PIB India states, 'National Regulator approves āConditional Market Authorizationā of two #COVID19Vaccines- Covaxin and Covishield Market Authorization conditional to submission of ongoing clinical trial data and safety data of the vaccine, at longer time intervals Details: ...'
National Regulator approves āConditional Market Authorizationā of two #COVID19Vaccines- Covaxin and Covishield
Market Authorization conditional to submission of ongoing clinical trial data and safety data of the vaccine, at longer time intervals
Details: https://t.co/LSY0eu6AdK— PIB India (@PIB_India) January 27, 2022
(The above story first appeared on LatestLY on Jan 27, 2022 05:01 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
